Medacta Group SA (SWX:MOVE)
Switzerland · Delayed Price · Currency is CHF 165.20
-4.40 (-2.59%)
At close: Jan 30, 2026
Medacta Group Market Cap
Medacta Group has a market cap or net worth of 3.29 billion as of January 30, 2026. Its market cap has increased by 51.51% in one year.
Market Cap
3.29B
Enterprise Value
3.50B
Revenue
603.41M
Ranking
n/a
PE Ratio
37.16
Stock Price
165.20
Market Cap Chart
Since April 4, 2019, Medacta Group's market cap has increased from 1.92B to 3.29B, an increase of 71.43%. That is a compound annual growth rate of 8.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 3.29B | 5.63% |
| Dec 30, 2025 | 3.12B | 46.66% |
| Dec 30, 2024 | 2.13B | -15.15% |
| Dec 29, 2023 | 2.51B | 21.81% |
| Dec 30, 2022 | 2.06B | -27.53% |
| Dec 30, 2021 | 2.84B | 62.08% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 4, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 299.12B |
| Novartis AG | 223.58B |
| Lonza Group AG | 39.22B |
| Galderma Group AG | 35.14B |
| Galenica AG | 4.85B |
| Siegfried Holding AG | 4.38B |
| Ypsomed Holding AG | 4.35B |
| Cosmo Pharmaceuticals | 1.89B |